Abstract
Some new papers coming from different Authors are here published, all yet concord in evaluating as excellent the effectiveness of Omalizumab in "difficult" allergic asthmatics. As in a few of the previous articles on Omalizumab published in the most recent issues of this Journal, some of the following case reports are characterized by the application of original evaluation criteria, all concord in defining the efficacy of the drug in treated patients.
| Original language | Italian |
|---|---|
| Pages (from-to) | 209-212 |
| Number of pages | 4 |
| Journal | GIMT - Giornale Italiano delle Malattie del Torace |
| Volume | 61 |
| Issue number | 3 |
| Publication status | Published - 2007 |
Fingerprint
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
Cite this
Roma, E., & Banfi, P. (2007). Indicatori diversi, concordi nella valutazione dell'efficacia di omalizumab. GIMT - Giornale Italiano delle Malattie del Torace, 61(3), 209-212.